注射用重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白治疗幼年特发性关节炎临床疗效的Meta分析(2)
95%CI = [1.38，16.21]，P = 0.01)，ESR(WMD = -0.82，95%CI =[-1.47，-0.16]，P < 0.02)，CRP(WMD = -0.65，95%CI = [-0.93，-0.38]，P < 0.000 01)，MMP(WMD = -0.82，95%CI = [-1.13，-0.51]，P < 0.000 01)were better than the control group.There was no statistically significant difference of TNF-α compared with the control group(WMD = -0.27，95%CI =[- 0.93，0.39]，P = 0.42).In this paper ......
您现在查看是摘要页，全文长 3369 字符。